Related Funds
Fund Name | Location |
Capital6 Eagle | - |
Croda International Plc | United Kingdom, York, Yorkshire and the Humber |
ESSEC Ventures | Cergy-pontoise, France, Ile-de-France |
First Seafront Fund | China, Guangdong, Shenzhen |
Hongfu Ruiying | China, Guangdong, Shenzhen |
Hongli Zhihui Group | China, Guangdong, Guangzhou |
Jinkai High-tech Investment | China, Japan, Kagoshima Prefecture |
Mitacs | British Columbia, Canada, Vancouver |
Moonwhale Ventures | Delaware, Ohio, United States |
OLMA Private Equity Fund | County Dublin, Dublin, Ireland |
PALgenesis | New York, New York, United States |
Poletowin Pitcrew Holding | Japan, Tokyo |
RCF Group | Ohio, United States, West Chester |
Rekanext | Central, Central Region, Singapore |
Sarona Ventures | Israel, Tel Aviv, Tel Aviv |
SCP Vitalife Partners | Pennsylvania, United States, Wayne |
The Shimizu Bank | Japan, Shizuoka, Shizuoka Prefecture |
Vestar Capital Partners | New York, New York, United States |
WSR Capital | Colorado, Highlands Ranch, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Antithesis | $47M | 13 Feb 2024 | Vienna, Virginia, United States | ||
Pluton Biosciences | $16M | 24 May 2023 | Saint Louis, Missouri, United States | ||
Neurolytic Healthcare | $3M | 27 Jul 2022 | Oxford, Oxfordshire, United Kingdom | ||
Yali Biosciences | $3M | 22 Feb 2022 | South San Francisco, California, United States | ||
AarogyaAI | $676K | 07 Jan 2022 | New Delhi, Delhi, India | ||
Adlumin, Inc | $25M | 07 Dec 2021 | Arlington, Virginia, United States | ||
Pluton Biosciences | $6M | 06 Oct 2021 | Saint Louis, Missouri, United States | ||
Gliknik | $11M | 24 Jun 2021 | Baltimore, Maryland, United States | ||
08 Feb 2021 | London, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Antithesis | $47M | 13 Feb 2024 | Vienna, Virginia, United States | ||
Pluton Biosciences | $16M | 24 May 2023 | Saint Louis, Missouri, United States | ||
Neurolytic Healthcare | $3M | 27 Jul 2022 | Oxford, Oxfordshire, United Kingdom | ||
Yali Biosciences | $3M | 22 Feb 2022 | South San Francisco, California, United States | ||
AarogyaAI | $676K | 07 Jan 2022 | New Delhi, Delhi, India | ||
Adlumin, Inc | $25M | 07 Dec 2021 | Arlington, Virginia, United States | ||
Pluton Biosciences | $6M | 06 Oct 2021 | Saint Louis, Missouri, United States | ||
Gliknik | $11M | 24 Jun 2021 | Baltimore, Maryland, United States | ||
08 Feb 2021 | London, England, United Kingdom |